{"id":"W2054717635","doi":"10.1111/bjd.12266","title":"A randomized phase 2a efficacy and safety trial of the topical <scp>J</scp> anus kinase inhibitor tofacitinib in the treatment of chronic plaque psoriasis","year":2013,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":202,"is_retracted":false,"has_abstract":true,"ca_institutions":"Probity Medical Research; Université de Montréal; Innovaderm (Canada)","funders":"Pfizer","keywords":"Tofacitinib; Medicine; Janus kinase inhibitor; Adverse effect; Tolerability; Discontinuation; Erythema; Dermatology; Psoriasis; Plaque psoriasis; Randomized controlled trial; Clinical endpoint; Internal medicine; Pharmacology; Rheumatoid arthritis","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003172685,0.0001911611,0.001148474,0.0001123013,0.0001066776,0.00001740091,0.0002573034,0.0002820897,0.00006890875],"category_scores_gemma":[0.0004255696,0.0001183904,0.0003986624,0.000137482,0.000523259,0.00008471482,0.00003167179,0.0002106788,0.000005767252],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00004598302,"about_ca_system_score_gemma":0.0001636493,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001639329,"about_ca_topic_score_gemma":0.00007105982,"domain_scores_codex":[0.9966497,0.001739528,0.001086154,0.0001626834,0.00007518381,0.000286702],"domain_scores_gemma":[0.9968159,0.002207734,0.0006446054,0.0001993938,0.00009917362,0.00003324295],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.3373156,0.01737705,0.002598828,0.0001544639,0.004127637,0.001762002,0.007546043,0.000007828573,0.02417719,0.0009779556,0.006383132,0.5975723],"study_design_scores_gemma":[0.9333491,0.001757206,0.003027251,0.0001581872,0.0005463238,0.01197314,0.0004276648,0.000003331151,0.04040528,0.0001838511,0.008094735,0.00007390219],"study_design_candidate":"randomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9795782,0.01756757,0.00001792304,0.0006009454,0.0008285535,0.001179599,0.00006082285,0.000004725782,0.0001616432],"genre_scores_gemma":[0.9941832,0.005453621,0.00003307832,0.00005184949,0.0001175335,0.00006750997,0.00001566897,0.000009320973,0.00006818815],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.5974984,"threshold_uncertainty_score":0.4827821,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01371388029658441,"score_gpt":0.2499637388244977,"score_spread":0.2362498585279132,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}